FStar Therapeutics
$7.12
5
-$0.00-0.07% Wednesday 20:55
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
156.4M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
13MarExpected
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-0.92
-0.45
0.01
0.48
Expected EPS
-0.51
Actual EPS
N/A
Financials
-149.14%Profit Margin
Unprofitable21.17MRevenue
-31.57MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow FSTX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Pharmaceuticals: Major
Manufacturing
Pharmaceutical Preparation Manufacturing
F-star Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops tetravalent bispecific antibodies for cancer therapy. Its medicines are used in immuno-oncology treatments. The company's principal product candidate is FS118 and is being evaluated in a proof-of-concept Phase 2 trial in PD-1/PD-L1 acquired resistance head and neck cancer patients. It is also developing first-in-human clinical study of FS222, a bispecific antibody that is in Phase 1 clinical trial targeting the costimulatory CD137 receptor and the inhibitory PD-L1 ligand. In addition, the company is also evaluating FS120 and SB 11285 for patients with advanced cancers, which are under Phase 1 clinical trials. F-star Therapeutics, Inc. was incorporated in 2002 and is headquartered in Cambridge, the United Kingdom.
Show more...
CEO
Employees
84
Country
United States
ISIN
US30315R1077
WKN
000A2QJEK
Listings
0 Comments
Share your thoughts
FAQ
What is FStar Therapeutics stock price today?▼
The current price of FSTX is $7.12 USD — it has decreased by -0.07% in the past 24 hours. Watch FStar Therapeutics stock price performance more closely on the chart.
What is FStar Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange FStar Therapeutics stocks are traded under the ticker FSTX.
What is FStar Therapeutics market cap?▼
Today FStar Therapeutics has the market capitalization of 156.4M
What is FStar Therapeutics revenue for the last year?▼
FStar Therapeutics revenue for the last year amounts to 21.17M USD.
What is FStar Therapeutics net income for the last year?▼
FSTX net income for the last year is -31.57M USD.
How many employees does FStar Therapeutics have?▼
As of July 10, 2026, the company has 84 employees.
In which sector is FStar Therapeutics located?▼
FStar Therapeutics operates in the Manufacturing sector.
When did FStar Therapeutics complete a stock split?▼
The last stock split for FStar Therapeutics was on November 23, 2020 with a ratio of 1:4.
Where is FStar Therapeutics headquartered?▼
FStar Therapeutics is headquartered in Hopkinton, United States.